scientist TakaraBio San Jose, California, United States
Urinary tract infections (UTIs) are common bacterial and fungal infections that are more accurately detected by molecular methods compared to culture-based methods, which are time-consuming, prone to contamination, and unable to identify multiple antibiotic-resistant genes (ARGs) in a single sample. However, existing UTI panels often face limitations with target pathogen identification and issues with false negatives and positives. To address these issues, we developed a comprehensive panel for UTIs, sexually transmitted infections (STIs), and wound infections, incorporating common ARG targets. Integrated with the high-density SmartChip® system, this panel includes a spiked-in exogenous DNA sequence to enhance detection precision and minimize false negatives.
